Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

3.605 +0.025 (+0.70%)
Streaming Delayed Price Updated: 12:54 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,285
Open 3.540
Bid (Size) 3.600 (13)
Ask (Size) 3.610 (10)
Prev. Close 3.580
Today's Range 3.480 - 3.630
52wk Range 2.370 - 7.630
Shares Outstanding 136,360,208
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Improved Sample Throughput, Automation Capabilities and Updated Hardware Design 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock
Via Benzinga

Performance

YTD
-45.1%
-45.1%
1 Month
+1.3%
+1.3%
3 Month
-3.6%
-3.6%
6 Month
-47.2%
-47.2%
1 Year
-37.2%
-37.2%

More News

Read More
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Cytek Biosciences Reports First Quarter 2025 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Preview: Cytek Biosciences's Earnings
Via Benzinga
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
From Cytek Biosciences, Inc.
Via GlobeNewswire
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
Via Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
Via Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
From Cytek Biosciences, Inc.
Via GlobeNewswire
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Via Benzinga
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
From Cytek Biosciences, Inc.
Via GlobeNewswire
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences Announces $50 Million Stock Repurchase Program
From Cytek Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?
Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
What is the current price of Cytek Biosciences, Inc. - Common Stock?
The current price of Cytek Biosciences, Inc. - Common Stock is 3.605
When was Cytek Biosciences, Inc. - Common Stock last traded?
The last trade of Cytek Biosciences, Inc. - Common Stock was at 07/10/25 12:54 PM ET
What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
The market capitalization of Cytek Biosciences, Inc. - Common Stock is 491.58M
How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
Cytek Biosciences, Inc. - Common Stock has 492M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.